The FDA vows to go after stem cell clinics that are pushing a dangerous experimental treatment to cancer patients, a treatment developed by mixing stem cells with the small pox vaccine.
The agency started the crackdown with two large stem cells clinic as well as a biotech firm, noting that the FDA will shut down “unscrupulous actors involved in regenerative medicine.”
Although stem cell treatments have gained popularity over the years, the FDA has only approved a few stem-cell products.
The FDA has just released a statement about its crackdown on a California company pushing an unapproved treatment for cancer patients: stem cells mixed with a smallpox vaccine.
But that’s not the big story. The big story is buried in the FDA press release. Here is the Agency’s statement:
“Serious health problems, including those that are life-threatening, can also occur in…people who…have problems with their heart or immune system if they become infected with the [smallpox] vaccine virus, either by being vaccinated or by being in close contact with a person who was vaccinated.”
The FDA states that those with certain prior health conditions who pick up the smallpox virus, as a result of vaccination, are at exceptionally high risk. AMONG THOSE PRIOR HEALTH CONDITIONS IS: “IMMUNE SYSTEM PROBLEMS.”
That simply means weak and compromised immune systems.
And yet…during the years 1966-1980, a massive smallpox eradication campaign was carried out in Africa, under the auspices of the World Health Organization. Roughly 100 million doses of the smallpox vaccine were given to Africans, MANY OF WHOM ALREADY HAD COMPROMISED IMMUNE SYSTEMS.
Image courtesy of: UCL News